Merck stops testing combo drug for skin cancer as more patients discontinue - Reuters

Reuters | May 13, 2024, 8:55 a.m. | Original
Merck stops testing combo drug for skin cancer as more patients discontinue Reuters
UBS CEO says Switzerland should not "overshoot" with capital demands - Reuters Brazilian airline Azul's losses narrow in first quarter - Reuters